Brendan D. Manning, Ph.D. - Publications

Affiliations: 
2000 Yale University, New Haven, CT 

84 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Sahin M, Henske EP, Manning BD, Ess KC, Bissler JJ, Klann E, Kwiatkowski DJ, Roberds SL, Silva AJ, Hillaire-Clarke CS, Young LR, Zervas M, Mamounas LA. Advances and Future Directions for Tuberous Sclerosis Complex Research: Recommendations From the 2015 Strategic Planning Conference. Pediatric Neurology. PMID 27267556 DOI: 10.1016/j.pediatrneurol.2016.03.015  1
2016 Hallett JE, Manning BD. CASTORing New Light on Amino Acid Sensing. Cell. 165: 15-7. PMID 27015302 DOI: 10.1016/j.cell.2016.03.002  1
2016 Ben-Sahra I, Hoxhaj G, Ricoult SJ, Asara JM, Manning BD. mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle. Science (New York, N.Y.). 351: 728-33. PMID 26912861 DOI: 10.1126/science.aad0489  1
2016 Covarrubias AJ, Aksoylar HI, Yu J, Snyder NW, Worth AJ, Iyer SS, Wang J, Ben-Sahra I, Byles V, Polynne-Stapornkul T, Espinosa EC, Lamming D, Manning BD, Zhang Y, Blair IA, et al. Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation. Elife. 5. PMID 26894960 DOI: 10.7554/eLife.11612  1
2016 Zhang Y, Manning BD. Zhang & Manning reply. Nature. 529: E2-3. PMID 26791732 DOI: 10.1038/nature16473  1
2015 Housden BE, Valvezan AJ, Kelley C, Sopko R, Hu Y, Roesel C, Lin S, Buckner M, Tao R, Yilmazel B, Mohr SE, Manning BD, Perrimon N. Identification of potential drug targets for tuberous sclerosis complex by synthetic screens combining CRISPR-based knockouts with RNAi. Science Signaling. 8: rs9. PMID 26350902 DOI: 10.1126/scisignal.aab3729  1
2015 Ricoult SJ, Yecies JL, Ben-Sahra I, Manning BD. Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP. Oncogene. PMID 26028026 DOI: 10.1038/onc.2015.179  1
2015 Zhang Y, Manning BD. mTORC1 signaling activates NRF1 to increase cellular proteasome levels. Cell Cycle (Georgetown, Tex.). 14: 2011-7. PMID 26017155 DOI: 10.1080/15384101.2015.1044188  1
2015 Priolo C, Ricoult SJ, Khabibullin D, Filippakis H, Yu J, Manning BD, Clish C, Henske EP. Tuberous Sclerosis Complex 2 Loss Increases Lysophosphatidylcholine Synthesis in Lymphangioleiomyomatosis. American Journal of Respiratory Cell and Molecular Biology. 53: 33-41. PMID 25780943 DOI: 10.1165/rcmb.2014-0379RC  1
2014 Dowdle WE, Nyfeler B, Nagel J, Elling RA, Liu S, Triantafellow E, Menon S, Wang Z, Honda A, Pardee G, Cantwell J, Luu C, Cornella-Taracido I, Harrington E, Fekkes P, ... ... Manning BD, et al. Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo. Nature Cell Biology. 16: 1069-79. PMID 25327288 DOI: 10.1038/ncb3053  1
2014 Liu XS, Haines JE, Mehanna EK, Genet MD, Ben-Sahra I, Asara JM, Manning BD, Yuan ZM. ZBTB7A acts as a tumor suppressor through the transcriptional repression of glycolysis. Genes & Development. 28: 1917-28. PMID 25184678 DOI: 10.1101/gad.245910.114  1
2014 Kwiatkowski DJ, Manning BD. Molecular basis of giant cells in tuberous sclerosis complex. The New England Journal of Medicine. 371: 778-80. PMID 25140966 DOI: 10.1056/NEJMcibr1406613  1
2014 Harputlugil E, Hine C, Vargas D, Robertson L, Manning BD, Mitchell JR. The TSC complex is required for the benefits of dietary protein restriction on stress resistance in vivo. Cell Reports. 8: 1160-70. PMID 25131199 DOI: 10.1016/j.celrep.2014.07.018  1
2014 Zhang Y, Nicholatos J, Dreier JR, Ricoult SJ, Widenmaier SB, Hotamisligil GS, Kwiatkowski DJ, Manning BD. Coordinated regulation of protein synthesis and degradation by mTORC1. Nature. 513: 440-3. PMID 25043031 DOI: 10.1038/nature13492  1
2014 Lall R, Ganapathy S, Yang M, Xiao S, Xu T, Su H, Shadfan M, Asara JM, Ha CS, Ben-Sahra I, Manning BD, Little JB, Yuan ZM. Low-dose radiation exposure induces a HIF-1-mediated adaptive and protective metabolic response. Cell Death and Differentiation. 21: 836-44. PMID 24583639 DOI: 10.1038/cdd.2014.24  1
2014 Menon S, Dibble CC, Talbott G, Hoxhaj G, Valvezan AJ, Takahashi H, Cantley LC, Manning BD. Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome. Cell. 156: 771-85. PMID 24529379 DOI: 10.1016/j.cell.2013.11.049  1
2013 Byles V, Covarrubias AJ, Ben-Sahra I, Lamming DW, Sabatini DM, Manning BD, Horng T. The TSC-mTOR pathway regulates macrophage polarization. Nature Communications. 4: 2834. PMID 24280772 DOI: 10.1038/ncomms3834  1
2013 Liu P, Gan W, Inuzuka H, Lazorchak AS, Gao D, Arojo O, Liu D, Wan L, Zhai B, Yu Y, Yuan M, Kim BM, Shaik S, Menon S, Gygi SP, ... ... Manning BD, et al. Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis. Nature Cell Biology. 15: 1340-50. PMID 24161930 DOI: 10.1038/ncb2860  1
2013 Kelsey I, Manning BD. mTORC1 status dictates tumor response to targeted therapeutics. Science Signaling. 6: pe31. PMID 24065143 DOI: 10.1126/scisignal.2004632  1
2013 Ersoy BA, Tarun A, D'Aquino K, Hancer NJ, Ukomadu C, White MF, Michel T, Manning BD, Cohen DE. Phosphatidylcholine transfer protein interacts with thioesterase superfamily member 2 to attenuate insulin signaling. Science Signaling. 6: ra64. PMID 23901139 DOI: 10.1126/scisignal.2004111  1
2013 Howell JJ, Ricoult SJ, Ben-Sahra I, Manning BD. A growing role for mTOR in promoting anabolic metabolism. Biochemical Society Transactions. 41: 906-12. PMID 23863154 DOI: 10.1042/BST20130041  1
2013 Menon S, Manning BD. Cell signalling: nutrient sensing lost in cancer. Nature. 498: 444-5. PMID 23803840 DOI: 10.1038/498444a  1
2013 Tintoré M, Gállego I, Manning B, Eritja R, Fàbrega C. DNA origami as a DNA repair nanosensor at the single-molecule level Angewandte Chemie - International Edition. 52: 7747-7750. PMID 23766021 DOI: 10.1002/anie.201301293  1
2013 Manning BD. Adaptation to starvation: translating a matter of life or death. Cancer Cell. 23: 713-5. PMID 23763997 DOI: 10.1016/j.ccr.2013.05.012  1
2013 Dibble CC, Manning BD. Signal integration by mTORC1 coordinates nutrient input with biosynthetic output. Nature Cell Biology. 15: 555-64. PMID 23728461 DOI: 10.1038/ncb2763  1
2013 Liu Y, Marks K, Cowley GS, Carretero J, Liu Q, Nieland TJ, Xu C, Cohoon TJ, Gao P, Zhang Y, Chen Z, Altabef AB, Tchaicha JH, Wang X, Choe S, ... ... Manning BD, et al. Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer. Cancer Discovery. 3: 870-9. PMID 23715154 DOI: 10.1158/2159-8290.CD-13-0015  1
2013 Ben-Sahra I, Howell JJ, Asara JM, Manning BD. Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1. Science (New York, N.Y.). 339: 1323-8. PMID 23429703 DOI: 10.1126/science.1228792  1
2013 Ricoult SJ, Manning BD. The multifaceted role of mTORC1 in the control of lipid metabolism. Embo Reports. 14: 242-51. PMID 23399656 DOI: 10.1038/embor.2013.5  1
2012 Dibble CC, Elis W, Menon S, Qin W, Klekota J, Asara JM, Finan PM, Kwiatkowski DJ, Murphy LO, Manning BD. TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. Molecular Cell. 47: 535-46. PMID 22795129 DOI: 10.1016/j.molcel.2012.06.009  1
2012 Manning BD. Comment on "A dynamic network model of mTOR signaling reveals TSC-independent mTORC2 regulation": building a model of the mTOR signaling network with a potentially faulty tool. Science Signaling. 5: lc3; author reply lc. PMID 22786721 DOI: 10.1126/scisignal.2003250  1
2012 Menon S, Yecies JL, Zhang HH, Howell JJ, Nicholatos J, Harputlugil E, Bronson RT, Kwiatkowski DJ, Manning BD. Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice. Science Signaling. 5: ra24. PMID 22457330 DOI: 10.1126/scisignal.2002739  1
2012 Auricchio N, Malinowska I, Shaw R, Manning BD, Kwiatkowski DJ. Therapeutic trial of metformin and bortezomib in a mouse model of tuberous sclerosis complex (TSC). Plos One. 7: e31900. PMID 22363765 DOI: 10.1371/journal.pone.0031900  1
2012 Manning B, Eritja R. Functionalization of surfaces with synthetic oligonucleotides Methods in Molecular Biology. 811: 89-100. PMID 22042674 DOI: 10.1007/978-1-61779-388-2_6  1
2011 Tanaka K, Babic I, Nathanson D, Akhavan D, Guo D, Gini B, Dang J, Zhu S, Yang H, De Jesus J, Amzajerdi AN, Zhang Y, Dibble CC, Dan H, Rinkenbaugh A, ... ... Manning BD, et al. Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance. Cancer Discovery. 1: 524-38. PMID 22145100 DOI: 10.1158/2159-8290.CD-11-0124  1
2011 Manning B, Eritja R. Use of oligonucleotides carrying photolabile groups for the control of the deposition of nanoparticles in surfaces and nanoparticle association International Journal of Molecular Sciences. 12: 7238-7249. PMID 22072944 DOI: 10.3390/ijms12107238  1
2011 De Raedt T, Walton Z, Yecies JL, Li D, Chen Y, Malone CF, Maertens O, Jeong SM, Bronson RT, Lebleu V, Kalluri R, Normant E, Haigis MC, Manning BD, Wong KK, et al. Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors. Cancer Cell. 20: 400-13. PMID 21907929 DOI: 10.1016/j.ccr.2011.08.014  1
2011 Yecies JL, Zhang HH, Menon S, Liu S, Yecies D, Lipovsky AI, Gorgun C, Kwiatkowski DJ, Hotamisligil GS, Lee CH, Manning BD. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metabolism. 14: 21-32. PMID 21723501 DOI: 10.1016/j.cmet.2011.06.002  1
2011 Yecies JL, Manning BD. Transcriptional control of cellular metabolism by mTOR signaling. Cancer Research. 71: 2815-20. PMID 21487041 DOI: 10.1158/0008-5472.CAN-10-4158  1
2011 Yecies JL, Manning BD. mTOR links oncogenic signaling to tumor cell metabolism. Journal of Molecular Medicine (Berlin, Germany). 89: 221-8. PMID 21301797 DOI: 10.1007/s00109-011-0726-6  1
2011 Howell JJ, Manning BD. mTOR couples cellular nutrient sensing to organismal metabolic homeostasis. Trends in Endocrinology and Metabolism: Tem. 22: 94-102. PMID 21269838 DOI: 10.1016/j.tem.2010.12.003  1
2010 Manning BD. Insulin signaling: inositol phosphates get into the Akt. Cell. 143: 861-3. PMID 21145450 DOI: 10.1016/j.cell.2010.11.040  1
2010 Düvel K, Yecies JL, Menon S, Raman P, Lipovsky AI, Souza AL, Triantafellow E, Ma Q, Gorski R, Cleaver S, Vander Heiden MG, MacKeigan JP, Finan PM, Clish CB, Murphy LO, ... Manning BD, et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Molecular Cell. 39: 171-83. PMID 20670887 DOI: 10.1016/j.molcel.2010.06.022  1
2010 Yecies JL, Manning BD. Chewing the fat on tumor cell metabolism. Cell. 140: 28-30. PMID 20085702 DOI: 10.1016/j.cell.2009.12.037  1
2010 Manning B, Leigh SJ, Ramos R, Preece JA, Eritja R. Fabrication of patterned surfaces by photolithographic exposure of dna hairpins carrying a novel photolabile group Journal of Experimental Nanoscience. 5: 26-39. DOI: 10.1080/17458080903242314  1
2010 Dibble CC, Manning BD. The TSC1-TSC2 complex. A key signal-integrating node upstream of TOR Enzymes. 28: 21-48. DOI: 10.1016/S1874-6047(10)28002-2  1
2010 Manning BD. The Role of Target of Rapamycin Signaling in Tuberous Sclerosis Complex Tuberous Sclerosis Complex: Genes, Clinical Features and Therapeutics. 85-115. DOI: 10.1002/9783527630073.ch6  1
2009 Dibble CC, Manning BD. A molecular link between AKT regulation and chemotherapeutic response. Cancer Cell. 16: 178-80. PMID 19732717 DOI: 10.1016/j.ccr.2009.08.011  1
2009 Dibble CC, Asara JM, Manning BD. Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1. Molecular and Cellular Biology. 29: 5657-70. PMID 19720745 DOI: 10.1128/MCB.00735-09  1
2009 Reiriz C, Brea RJ, Arranz R, Carrascosa JL, Garibotti A, Manning B, Valpuesta JM, Eritja R, Castedo L, Granja JR. α,γ-Peptide nanotube templating of one-dimensional parallel fullerene arrangements Journal of the American Chemical Society. 131: 11335-11337. PMID 19630409 DOI: 10.1021/ja904548q  1
2009 Huang J, Wu S, Wu CL, Manning BD. Signaling events downstream of mammalian target of rapamycin complex 2 are attenuated in cells and tumors deficient for the tuberous sclerosis complex tumor suppressors. Cancer Research. 69: 6107-14. PMID 19602587 DOI: 10.1158/0008-5472.CAN-09-0975  1
2009 Zhang HH, Huang J, Düvel K, Boback B, Wu S, Squillace RM, Wu CL, Manning BD. Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway. Plos One. 4: e6189. PMID 19593385 DOI: 10.1371/journal.pone.0006189  1
2009 James MF, Han S, Polizzano C, Plotkin SR, Manning BD, Stemmer-Rachamimov AO, Gusella JF, Ramesh V. NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth. Molecular and Cellular Biology. 29: 4250-61. PMID 19451225 DOI: 10.1128/MCB.01581-08  1
2009 Manning BD. Challenges and opportunities in defining the essential cancer kinome. Science Signaling. 2: pe15. PMID 19318621 DOI: 10.1126/scisignal.263pe15  1
2009 Huang J, Manning BD. A complex interplay between Akt, TSC2 and the two mTOR complexes. Biochemical Society Transactions. 37: 217-22. PMID 19143635 DOI: 10.1042/BST0370217  1
2009 Manning B, Pérez-Rentero S, Garibotti AV, Ramos R, Eritia R. Modified oligonucleotides for biosensing applications Sensor Letters. 7: 774-781. DOI: 10.1166/sl.2009.1147  1
2009 Manning BD, VanHook AM. Science signaling podcast: 07 April 2009 Science Signaling. 2: pc7. DOI: 10.1126/scisignal.265pc7  1
2009 Ramos R, Manning B, Aviñó A, Gargallo R, Eritja R. Photocleavage of peptides and oligodeoxynucleotides carrying 2-nitrobenzyl groups Helvetica Chimica Acta. 92: 613-622. DOI: 10.1002/hlca.200800361  1
2008 Menon S, Manning BD. Common corruption of the mTOR signaling network in human tumors. Oncogene. 27: S43-51. PMID 19956179 DOI: 10.1038/onc.2009.352  1
2008 Chakrabarti P, Anno T, Manning BD, Luo Z, Kandror KV. The mammalian target of rapamycin complex 1 regulates leptin biosynthesis in adipocytes at the level of translation: the role of the 5'-untranslated region in the expression of leptin messenger ribonucleic acid. Molecular Endocrinology (Baltimore, Md.). 22: 2260-7. PMID 18653778 DOI: 10.1210/me.2008-0148  1
2008 Huang J, Manning BD. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. The Biochemical Journal. 412: 179-90. PMID 18466115 DOI: 10.1042/BJ20080281  1
2008 Huang J, Dibble CC, Matsuzaki M, Manning BD. The TSC1-TSC2 complex is required for proper activation of mTOR complex 2. Molecular and Cellular Biology. 28: 4104-15. PMID 18411301 DOI: 10.1128/MCB.00289-08  1
2008 Ozcan U, Ozcan L, Yilmaz E, Düvel K, Sahin M, Manning BD, Hotamisligil GS. Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis. Molecular Cell. 29: 541-51. PMID 18342602 DOI: 10.1016/j.molcel.2007.12.023  1
2008 Mazzini S, García-Martin F, Alvira M, Aviñó A, Manning B, Albericio F, Eritja R. Synthesis of oligonucleotide derivatives using ChemMatrix supports Chemistry and Biodiversity. 5: 209-218. PMID 18205124 DOI: 10.1002/cbdv.200890012  1
2007 Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell. 129: 1261-74. PMID 17604717 DOI: 10.1016/j.cell.2007.06.009  1
2006 Zhang HH, Lipovsky AI, Dibble CC, Sahin M, Manning BD. S6K1 regulates GSK3 under conditions of mTOR-dependent feedback inhibition of Akt. Molecular Cell. 24: 185-97. PMID 17052453 DOI: 10.1016/j.molcel.2006.09.019  1
2006 Sodhi A, Chaisuparat R, Hu J, Ramsdell AK, Manning BD, Sausville EA, Sawai ET, Molinolo A, Gutkind JS, Montaner S. The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. Cancer Cell. 10: 133-43. PMID 16904612 DOI: 10.1016/j.ccr.2006.05.026  1
2005 Kwiatkowski DJ, Manning BD. Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Human Molecular Genetics. 14: R251-8. PMID 16244323 DOI: 10.1093/hmg/ddi260  1
2005 Manning BD, Logsdon MN, Lipovsky AI, Abbott D, Kwiatkowski DJ, Cantley LC. Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2. Genes & Development. 19: 1773-8. PMID 16027169 DOI: 10.1101/gad.1314605  1
2005 Manning B, Di Salvo A, Stanca S, Ongaro A, Fitzmaurice D. DNA-templated assembly of nanoscale wires and switches Proceedings of Spie - the International Society For Optical Engineering. 5824: 93-101. DOI: 10.1117/12.601447  1
2004 Manning BD. Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis. The Journal of Cell Biology. 167: 399-403. PMID 15533996 DOI: 10.1083/jcb.200408161  1
2004 Shaw RJ, Bardeesy N, Manning BD, Lopez L, Kosmatka M, DePinho RA, Cantley LC. The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell. 6: 91-9. PMID 15261145 DOI: 10.1016/j.ccr.2004.06.007  1
2003 Manning BD, Cantley LC. Rheb fills a GAP between TSC and TOR. Trends in Biochemical Sciences. 28: 573-6. PMID 14607085 DOI: 10.1016/j.tibs.2003.09.003  1
2003 Luo J, Manning BD, Cantley LC. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell. 4: 257-62. PMID 14585353 DOI: 10.1016/S1535-6108(03)00248-4  1
2003 Tee AR, Manning BD, Roux PP, Cantley LC, Blenis J. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Current Biology : Cb. 13: 1259-68. PMID 12906785 DOI: 10.1016/S0960-9822(03)00506-2  1
2003 Manning BD, Cantley LC. United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signalling. Biochemical Society Transactions. 31: 573-8. PMID 12773158 DOI: 10.1042/  1
2002 Manning BD, Cantley LC. Hitting the target: emerging technologies in the search for kinase substrates. Science's Stke : Signal Transduction Knowledge Environment. 2002: pe49. PMID 12475999 DOI: 10.1126/stke.2002.162.pe49  1
2002 Tee AR, Fingar DC, Manning BD, Kwiatkowski DJ, Cantley LC, Blenis J. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proceedings of the National Academy of Sciences of the United States of America. 99: 13571-6. PMID 12271141 DOI: 10.1073/pnas.202476899  1
2002 Manning BD, Tee AR, Logsdon MN, Blenis J, Cantley LC. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Molecular Cell. 10: 151-62. PMID 12150915 DOI: 10.1016/S1097-2765(02)00568-3  1
2001 De Diego JL, Katz JM, Marshall P, Manning B, Gutiérrez JE, Nussenzweig V, González J. The ubiquitin-proteasome pathway plays an essential role in proteolysis during Trypanosoma cruzi remodeling Biochemistry. 40: 1053-1062. PMID 11170428 DOI: 10.1021/bi001659k  1
2000 Barrett JG, Manning BD, Snyder M. The Kar3p kinesin-related protein forms a novel heterodimeric structure with its associated protein Cik1p. Molecular Biology of the Cell. 11: 2373-85. PMID 10888675  1
2000 Manning BD, Snyder M. Drivers and passengers wanted! the role of kinesin-associated proteins. Trends in Cell Biology. 10: 281-9. PMID 10856931 DOI: 10.1016/S0962-8924(00)01774-8  1
1999 Manning BD, Barrett JG, Wallace JA, Granok H, Snyder M. Differential regulation of the Kar3p kinesin-related protein by two associated proteins, Cik1p and Vik1p. The Journal of Cell Biology. 144: 1219-33. PMID 10087265 DOI: 10.1083/jcb.144.6.1219  1
1997 Manning BD, Padmanabha R, Snyder M. The Rho-GEF Rom2p localizes to sites of polarized cell growth and participates in cytoskeletal functions in Saccharomyces cerevisiae. Molecular Biology of the Cell. 8: 1829-44. PMID 9348527  1
1996 Lessie TG, Hendrickson W, Manning BD, Devereux R. Genomic complexity and plasticity of Burkholderia cepacia. Fems Microbiology Letters. 144: 117-28. PMID 8900054 DOI: 10.1016/0378-1097(96)00343-6  1
Show low-probability matches.